About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of DER 45-EV Gel to Treat Rosacea | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00940992

A Study of DER 45-EV Gel to Treat Rosacea

To identify lowest efficacious dose of DER 45 EV Gel, 1% and 5% verses vehicle in patients with rosacea.

Lead sponsor: Sol-Gel Technologies, Ltd.•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Sol-Gel Technologies, Ltd.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Males and females, 18 years of age or older
•Facial rosacea, with 12 or more inflammatory lesions (with no more than 2 nodules)
•Mild, Moderate or Severe (2, 3 or 4) rating of rosacea on the IGA
•Females of child-bearing potential must have negative urine pregnancy test result at baseline and must be willing to use an effective form of contraception throughout the study

Exclusion Criteria

•Subjects who are pregnant, breast feeding, or planning a pregnancy during the study
•Allergy or sensitivity to ingredients in test product
•Any dermatological conditions of the face that may interfere with study evaluations
•Subjects unable to avoid or minimize exposure to factors that may exacerbate or trigger rosacea

Related studies

Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin

NCT07106957 · Erythematous Telangiectatic Rosacea

Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort

NCT06466018 · Ocular Rosacea, Pachychoroid Disease

Active Not RecruitingEARLY Phase 1

Analysis of the Microbiome in Rosacea

NCT04108897 · Rosacea

Combined Therapy of 532-nm KTP and Microsecond 1064-nm Nd:YAG Laser for Rosacea

NCT07250165 · Rosacea

A Pilot Study to Explore the Role of Gut Flora in Acne

NCT04214483 · Acne, Acne Vulgaris, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment92

Start dateJan 2012

Last updatedJan 9, 2015

Condition

Locations shown

Baumann Cosmetic & Research Institute

Miami, Florida

FXM Research Corp

Miami, Florida

Augusta Centre for Dermatology and Skin

Augusta, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions